Combating HIV Stigma in Healthcare Settings: A Standardized Patient Approach
Launched by UNIVERSITY OF MINNESOTA · May 7, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on reducing stigma that sexual minorities and people living with HIV face in healthcare settings. The researchers aim to create and test a training program specifically for medical providers, such as doctors who specialize in sexual health medicine, in China. By improving how healthcare providers interact with these communities, the study hopes to create a more supportive and understanding environment for patients.
To participate in this trial, healthcare facilities must be accredited medical centers in China with specific testing capabilities for HIV and syphilis. The medical providers who are eligible to take part in the training must be licensed to practice sexually transmitted disease care at the time of the study. The trial is not yet recruiting participants, but it will eventually involve healthcare providers working to improve their knowledge and attitudes towards sexual health and HIV, ultimately benefiting patients who seek care.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Eligible facilities are those with
- • formal government accreditation as a medical center (a basic tenet of all public hospitals in China); and
- • possession of an accredited on-site laboratory with capacity to provide enzyme- linked immunosorbent assay testing for HIV, treponemal (e.g. Treponema pallidum particle agglutination) and non-treponemal tests (e.g. rapid plasma regain) for syphilis. Within eligible and consenting facilities, eligible providers are those who are licensed at the time of the study to practice STD care in China.
- Exclusion Criteria:
- • None
About University Of Minnesota
The University of Minnesota is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct cutting-edge studies aimed at improving patient outcomes and addressing critical health challenges. Its robust clinical trial program emphasizes ethical standards, patient safety, and scientific rigor, contributing to the development of novel therapies and interventions that enhance medical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Kumi Smith, PhD
Principal Investigator
University of Minnesota
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported